Sector Watch: Healthcare - Mar 26 2019
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $110.33 +2.01 1.86% | XBI: $89.72 +1.73 1.97% | Updated Mar 26, 2019 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| ALDX Aldeyra Therapeutics $266.0M |
9.71+2.57 21.4 M 69.0x |
36% | ||
| ORTX52WH Orchard Therapeutics $1.6B |
19.01+2.41 101.4 K |
15% | ||
| INFI Infinity Pharmaceuticals $106.5M |
1.87+0.17 369.4 K |
10% | ||
| INCR INC Research Holdings $1.2B |
1,147.00+102.00 612.0 K |
10% | ||
| PRTO Proteon Therapeutics $72.0M |
3.74+0.33 247.8 K |
10% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| AXSM52WH Axsome Therapeutics $477.2M |
14.34-2.00 2.0 M 1.9x |
-12% | ||
| MOH Molina Healthcare Inc $8.2B |
130.21-14.01 1.4 M |
-10% | ||
| ABMD ABIOMED $12.9B |
286.00-27.22 1.7 M 4.2x |
-9% | ||
| NEOG52WL Neogen $2.9B |
55.50-5.03 1.5 M 8.6x |
-8% | ||
| CRMD CorMedix Inc $906.9M |
7.62-0.68 754.4 K |
-8% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
The Alliance for Regenerative Medicine Announces Final Agenda for 2019 Cell & Gene Meeting on the Mediterranean [globenewswire.com]Impella RP Post-Approval Study Data Presented at ACC 2019 [businesswire.com]
Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer [globenewswire.com]
Impella RP Post-Approval Study Data Presented at ACC 2019 | Business Wire [businesswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
